-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Pharmaceutical Manufacturers
-
Hospital and Healthcare Providers
-
Pharmacy
-
Governments
-
Private Payers and Insurers
-
Academics and Researchers
Pharmaceutical Manufacturers
Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.
Learn MorePHARMACEUTICAL MANUFACTURERS QUICK LINKS
Hospital and Healthcare Providers
Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.
Learn MorePharmacy
A specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.
Learn MorePHARMACY QUICK LINKS
Governments
Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn More
Private Payers and Insurers
Health benefit analytics for effective response to market changes.
Learn More
Academics and Researchers
Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.
Learn MoreINSIGHTS
Explore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.
Learn MorePHARMACEUTICAL TRENDS
Media representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.
Learn More
WHITE PAPER
Access to oncology pharmaceutical innovations in Canada
Jul 27, 2023
In Canada, cancer is the leading cause of death. More than two in five Canadians can expect to be diagnosed with cancer at some point in their lives. Consequently, oncology is the leading therapeutic class in pharmaceutical sales in the country.
Fortunately, enormous strides have been made in recent years in the identification, diagnosis, and treatment for many cancer types. With innovation accelerating in this critical area of patient care, we examine the current market access landscape in Canada and identify hurdles that exist in providing patients with timely access to leading-edge treatments.
This paper looks at Canada's place in the global launch sequence of new oncology products, discusses precision medicine and companion diagnostics, and examines referral patterns and awareness of CAR T-cell therapies by oncologists using IQVIA's Canadian CAR-T Monitor data.
Fortunately, enormous strides have been made in recent years in the identification, diagnosis, and treatment for many cancer types. With innovation accelerating in this critical area of patient care, we examine the current market access landscape in Canada and identify hurdles that exist in providing patients with timely access to leading-edge treatments.
This paper looks at Canada's place in the global launch sequence of new oncology products, discusses precision medicine and companion diagnostics, and examines referral patterns and awareness of CAR T-cell therapies by oncologists using IQVIA's Canadian CAR-T Monitor data.
Have questions? Want to find out more?
We'd love to discuss how we can help address your business needs.
Send us a message and we'll connect you to a dedicated expert to answer your questions.